title: [Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
abstract: In the multidisciplinary Dutch guideline on Cardiovascular Risk Management (revision 2011) the recommendation for preventive treatment of elevated risks of cardiovascular disease in patients with arthritis lacks a trial-based justification. This section should therefore be removed. Introduction of clinical guidelines with recommendations justified by evidence of an unacceptably low grade is a growing international tendency that should be stopped.
authors.affiliation: Erasmus Medisch Centrum, afd. Huisartsgeneeskunde, Rotterdam, the Netherlands. s.thomas@erasmusmc.nl
authors.forename: Siep
authors.initials: S
authors.lastname: Thomas
mesh_terms: D001172:Arthritis, Rheumatoid / Q000150:complications*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors